Carregant...
Cell transfer immunotherapy for metastatic solid cancer—what clinicians need to know
Cancer immunotherapy using the adoptive transfer of autologous tumor-infiltrating lymphocytes results in objective cancer regression in 49–72% of patients with metastatic melanoma. In a pilot trial combining cell transfer with a maximum lymphodepleting regimen, complete durable responses were seen i...
Guardat en:
| Publicat a: | Nat Rev Clin Oncol |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6292196/ https://ncbi.nlm.nih.gov/pubmed/21808266 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2011.116 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|